In search for other factors that might cause resistance to AMG330, Harrington et al. found that a favorable response correlated with the number of endogenous T cells, while the levels of CD33 in AML blasts, disease-risks and drug resistance did not correlate with responses [91]. Here, CD33 is linked to acute myeloid leukemia.